Pacific Biosciences of California, Inc. (PACB)
1.135
-0.02
(-1.30%)
USD |
NASDAQ |
May 19, 12:07
Pacific Biosciences of California EPS Diluted (Quarterly) : -0.0271 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GE Healthcare Technologies, Inc. | 0.8512 |
| Globus Medical, Inc. | 0.8995 |
| Revvity, Inc. | 0.364 |
| Bruker Corp. | 0.0229 |
| Azenta, Inc. | -3.491 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.275M |
| Revenue (Quarterly) | 37.18M |
| Total Expenses (Quarterly) | 45.45M |
| Enterprise Value | 784.60M |
| Gross Profit Margin (Quarterly) | 32.30% |
| Profit Margin (Quarterly) | -22.26% |
| Earnings Yield | -37.60% |
| Normalized Earnings Yield | -28.71 |